SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001213900-22-004799
Filing Date
2022-02-01
Accepted
2022-02-01 16:15:42
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-3 ea154275-f3a1_tizianalife.htm F-3/A 273136
2 OPINION OF CONYERS DILL & PEARMAN LIMITED ea154275ex5-1_tizianalife.htm EX-5.1 10574
3 CONSENT OF MAZARS LLP ea154275ex23-1_tizianalife.htm EX-23.1 8066
4 CALCULATION OF THE FILING FEE TABLES. ea154275ex-fee_tizianalife.htm EX-FILING FEES 9234
5 GRAPHIC ex23-1_001.jpg GRAPHIC 6009
6 GRAPHIC img_001.jpg GRAPHIC 11377
7 GRAPHIC img_002.jpg GRAPHIC 29943
  Complete submission text file 0001213900-22-004799.txt   367684
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-252441 | Film No.: 22579119
SIC: 2834 Pharmaceutical Preparations